Microbiology and Molecular Biology Reviews, September 1999, p. 725-734, Vol. 63, No. 3
Department of Immunology, The Scripps
Research Institute, La Jolla, California 92037
1092-2172/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Role of
v Integrins in Adenovirus
Cell Entry and Gene Delivery
SUMMARY
INTRODUCTION
IN VITRO AND IN VIVO EVIDENCE THAT
V INTEGRINS PROMOTE ADENOVIRUS CELL ENTRY
ROLE OF DYNAMIN, ACTIN, AND CELL SIGNALING IN ADENOVIRUS
ENTRY
ROLE OF
V INTEGRINS IN
ADENOVIRUS-MEDIATED ENDOSOME DISRUPTION AND GENE DELIVERY
STRUCTURE OF A FUNCTION-BLOCKING MONOCLONAL ANTIBODY
COMPLEXED WITH ADENOVIRUS
STRUCTURE OF INTEGRIN
V
5 BOUND TO
ADENOVIRUS
OTHER VIRAL PATHOGENS THAT USE INTEGRINS FOR INFECTION
CONCLUSIONS AND FUTURE DIRECTIONS
ACKNOWLEDGMENTS
REFERENCES
SUMMARY
|
|
|---|
Adenoviruses (Ad) are a significant cause of acute infections in humans; however, replication-defective forms of this virus are currently under investigation for human gene therapy. Approximately 20 to 25% of all the gene therapy trials (phases I to III) conducted over the past 10 years involve the use of Ad gene delivery for treatment inherited or acquired diseases. At present, the most promising applications involve the use of Ad vectors to irradicate certain nonmetastatic tumors and to promote angiogenesis in order to alleviate cardiovascular disease. While specific problems of using Ad vectors remain to be overcome (as is true for almost all viral and nonviral delivery methods), a distinct advantage of Ad is the extensive knowledge of its macromolecular structure, genome organization, sequence, and mode of replication. Moreover, significant information has also been acquired on the interaction of Ad particles with distinct host cell receptors, events which strongly affect virus tropism. This review provides an overview of the structure and function of Ad attachment (coxsackievirus and Ad receptor [CAR]) and internalization (
v integrins) receptors and discusses their precise role in virus infection and gene delivery. Recent structure studies of integrin-Ad complexes by cryoelectron microscopy are also highlighted. Finally, unanswered questions arising from the current state of knowledge of Ad-receptor interactions are presented in the context of improving Ad vectors for future human gene therapy applications.
INTRODUCTION
|
|
|---|
Peter Medawar, who was awarded the 1960 Nobel Prize for Medicine and Physiology, defined a virus as a piece of nucleic acid surrounded by bad news (66). While this is certainly true of many human viruses, adenovirus (Ad) has also contributed significantly to the benefit of mankind. Ad represent a large family of nonenveloped viruses containing a double-stranded DNA genome of approximately 36 kb (43, 72). Human Ad, of which there are 50 different viral serotypes, are associated with respiratory, ocular, and gastrointestinal diseases. Ad infections are usually self-limiting; however, they can cause fatal disseminated disease in immunocompromised individuals (41, 58, 61, 62, 86). Despite its association with human diseases, Ad has also served as a valuable tool that has been used to uncover a number of important molecular and cell biological processes such as RNA processing (7, 15) and cell cycle regulation (14, 105).
An accumulation of information on the structure, molecular, and cell biology of Ad over the past several decades has also allowed the development of Ad vectors for in vivo gene therapy (10, 23, 53, 106). Multiple phase I or phase II clinical trials involving replication-defective forms of Ad to treat acquired and inherited diseases are underway. Some of the most encouraging uses of Ad vectors are those based on "conditional" replicating viruses for treating head and neck tumors (8). While several problems of using Ad vectors for in vivo gene therapy remain to be overcome, Ad vectors have already proven useful for studying the structure and function of various gene products in vitro (98).
Ad also offers several advantages for studying direct interactions of the virus with host cell receptors. Ad particles are stable and can be produced at high titers in human epithelial cell lines. In addition, several of the important coat proteins of the virus can be produced as soluble recombinant proteins in bacterial or insect cell expression systems, thus allowing analysis of their functional properties independent of the intact virion. Ad capsids are approximately 900 Å in diameter and have icosahedral symmetry. The virion contains 240 copies of the major coat protein, known as the hexon. Each of the 12 vertices of Ad also contains a complex, known as the penton, which is composed of the 320-kDa penton base and the 182-kDa fiber protein (88, 90). The Ad fiber protein mediates attachment to cells via interaction with a 46-kDa cell receptor designated CAR (coxsackievirus and Ad receptor) (5, 95) (Fig. 1). The penton base is composed of five identical polypeptide subunits, while the fiber contains three identical proteins. CAR serves as the receptor for many but not all Ad serotypes (47, 76). At present, all Ad serotypes except those belonging to subgroup B recognize CAR. The normal cellular function of CAR, a member of the immunoglobulin superfamily, has not yet been elucidated. The cytoplasmic domain of CAR is not required for virus attachment or infection (100), suggesting that cell signaling through this receptor is not involved in viral entry.
|
Efficient internalization of Ad into cells requires a second
interaction with a separate cell receptor. The Ad penton base protein
binds to integrins
v
3 and
v
5, and this promotes virus internalization (3, 104). In studies performed over 40 years ago (30, 71), the penton base was described as a
virus-associated toxic factor which caused cells to detach from their
substratum (the extracellular matrix) in culture. It is now known that
the penton base is not toxic but instead has the capacity to interfere with integrin interactions with the extracellular matrix, thereby promoting cell detachment in vitro. Integrins are relatively large heterodimeric transmembrane proteins composed of an
subunit and a
subunit (50). There are over 20 different members of the
integrin family, many of which recognize an arginine, glycine, aspartic
acid (RGD) sequence in host extracellular matrix proteins such as
vitronectin, fibronectin, and tenacin. Interactions of integrins with
these host cell ligands serve a number of important host cell functions
including cell attachment, migration, growth, and differentiation.
These functions are also reflected in the role of integrins in several
homeostatic processes including wound healing, osteogenesis, tumor
metastasis, and perhaps certain neuronal functions (40, 50).
Although Ad is the first virus that was shown to use distinct cellular
receptors for attachment (CAR) and internalization (
v
integrins), more recent studies have demonstrated that several enveloped viruses including human immunodeficiency virus type 1 (32), herpes simplex virus type 1 (35), and
adeno-associated virus (AAV) (92) use separate cell
receptors for attachment and entry. Of these, only AAV and Ad appear to
use
v integrins for entry. Other members of the integrin
family also promote the entry of different viruses (see "Other viral
pathogens that use integrins for infection" below), as well as
certain bacteria.
IN VITRO AND IN VIVO EVIDENCE THAT
V INTEGRINS PROMOTE ADENOVIRUS CELL ENTRY
|
|
|---|
Several lines of evidence indicate that interactions of Ad with
integrins promote virus internalization rather than attachment. Function-blocking antibodies directed against
v
integrins or RGD-synthetic peptides inhibit virus endocytosis and
infection but do not interfere with Ad attachment (104).
Recombinant Ad fiber but not the penton base competes for attachment
sites of viral particles (104). Moreover, the Ad2 fiber
protein has an approximately 50-fold-higher binding affinity for CAR
than the penton base has for
v integrins. Taken
together, these earlier studies indicated that the fiber protein
interaction with CAR facilitates virus attachment while the integrin
binding to the penton base enhances virus uptake into cells. At
present, it is not clear why CAR fails to promote virus
internalization. The role of CAR in normal host cell functions, if any,
also has not yet been established, and further knowledge of this may
shed light on its role in virus infection.
Another indication of the important role of interactions of
v integrin with Ad is that the penton base proteins of
multiple Ad serotypes from different virus subgroups contain a
conserved RGD motif (60). Different Ads also use integrins
for infection and/or bind to these receptors (59).
Preincubation of virus particles with soluble recombinant
v
5 integrin also inhibits Ad
internalization and virus-mediated gene delivery in vitro
(59).
One interesting feature of the Ad penton base is that the number of
amino acid residues flanking the RGD motif varies among the different
Ad serotypes. For example, sequence alignments have revealed that the
Ad12 penton base contains approximately 20 residues (87)
while that of Ad2/Ad5 has approximately 80 residues (64) (Fig. 2). An obvious question arising
from these findings is whether variations in the RGD-flanking sequences
influence integrin binding to the penton base. Studies such as those
with phage display libraries (42) may be helpful for the
identification of the precise amino acid residues in the penton base
that influence Ad-
v integrin interactions. Ad12 virions
are reported to be more susceptible to inhibition by anti-integrin
antibodies than are Ad2 virions (3), suggesting that Ad12
has lower intrinsic binding to
v-integrins than does
Ad2. This is supported by recent binding studies with soluble
recombinant integrin
v
5 (59).
Our structural studies also showed that soluble integrin
v
5 bound to Ad12 penton base has
restricted mobility compared to integrins bound to the Ad2 penton base,
which display a high degree of flexibility (14a). The
flexibility of the RGD loop in fibronectin, an extracellular matrix
protein, has also been postulated to play a role in integrin binding
(2, 18).
|
Although Ad from most subgroups use
v integrins for
infection, it is interesting that the penton base of Ad from subgroup F, serotypes 40/41, lacks the conserved RGD motif (25).
These enteric Ad which are quite difficult to propagate in vitro, may not interact with integrins. It will be of interest to determine whether they use an alternative cell entry pathway.
Given the conservation of the RGD integrin-binding motif among many different Ad serotypes, one might predict that introduction of a mutation in this sequence might negatively affect virus internalization and/or infection. In keeping with this prediction, a mutant Ad2 lacking the penton base RGD sequence was shown to have decreased infectivity in vitro (4). Interestingly, infection by the RGD mutant Ad was delayed but not completely abolished. These findings raise the possibility that virus infection can still occur in the absence of an integrin-penton base interaction. A likely scenario is that the fiber-CAR interaction is sufficient to allow virus entry, albeit at a significantly reduced internalization rate. An RGD mutant Ad bound to the surface of host cells via the CAR-fiber interaction but with a decreased capacity for internalization may be particularly vulnerable to attack in vivo by various components of the innate host defense system including proteolytic enzymes and complement (17). It remains to be determined whether the infectivity of such a mutant virus is significantly decreased in vivo.
The role of
v integrins in Ad infection and
virus-mediated gene delivery has also been revealed in a number of
other studies. Hematopoietic cells are notoriously difficult to infect
with Ad2/Ad5. A major block in infection appears to be the relatively
low abundance or absence of
v integrins on normal
peripheral blood mononuclear cells. Upregulation of
v
integrin expression on human monocytes by specific growth factors such
as macrophage colony-stimulating factor or granulocyte-macrophage
colony-stimulating factor (27) render these cells
susceptible to Ad-mediated gene delivery (45). An
interesting feature of Ad infection of monocytic cells is that these
cells also express relatively low levels of CAR. Virus attachment to
monocytes is mediated by the penton base interaction with integrin
m
2, while particle uptake is dependent
upon interactions with
v integrins (46).
Integrin expression is also upregulated on human B lymphocytes
following their infection and immortalization with Epstein-Barr virus,
and this greatly increases their susceptibility to Ad-mediated gene
delivery (48). Recently, multiple myeloma cells, but not
normal bone marrow-derived B cells, were found to express
v integrins, and this allowed targeting by a therapeutic Ad vector (94).
Several approaches have also been explored in an effort to overcome the lack of cell integrins and/or CAR on certain cell types to promote Ad infection. For example, Wickham et al. (103) modified Ad2 particles with a bispecific monoclonal antibody which recognized a synthetic peptide sequence incorporated into the RGD domain of the penton base and a T-lymphocyte-specific antigen, CD3. This modified virus significantly increased transduction of T lymphocytes in vitro. A potential problem with this approach is that the Fc region of cell-targeting antibodies may also direct the virus to Fc receptor-bearing cells including dendritic cells, macrophages, and B cells in vivo. High-efficiency gene transfer with Ad-polylysine-DNA complexes has also been reported (22).
As noted above, Ad vectors are currently under evaluation as gene
delivery vehicles for treating a number of genetic diseases including
cystic fibrosis. In addition to the inflammatory reactions to the viral
vector, another hindrance to gene delivery appears to be the lack of
integrin expression on the human airway epithelium (36).
Using a human bronchial xenograft model, Goldman and Wilson demonstrated that undifferentiated epithelial cells express high levels
of
v
5 integrins and are easily infected
with recombinant Ad (36). Ad-mediated gene delivery could
also be inhibited by function-blocking antibodies to
v
integrins or by RGD peptides. In contrast to undifferentiated
epithelial cells, pseudostratified epithelium containing columnar cells
expresses little or no
v integrin and is relatively
difficult to infect with Ad. More recent in vitro studies have
indicated that integrins are expressed on the basolateral surface of
poorly differentiated columnar epithelial cells but are present at very
low levels or absent on the apical surface of these cells
(73). The authors of this study failed to demonstrate a role
for
v integrins in Ad-mediated gene delivery. Integrins
may not be available for Ad interactions unless the regions of
cell-cell contact (tight junctions) are disrupted to expose their
basolateral surface.
Ad-mediated gene delivery is influenced not only by
v
integrin expression but also by the presence of the fiber receptor, CAR. For example, a recent study of Ad gene delivery to a panel of
human glioma cell lines indicated that Ad infection was dependent upon
the level of CAR expression rather than on the presence of
v integrins (63). CAR expression also
influences Ad-mediated gene delivery in the airway epithelium
(107). To circumvent the lack of CAR on certain cell types,
Dmitriev et al. (28) used a recombinant Ad vector in which
an RGD sequence was inserted into an exposed loop on the fiber knob
domain. This modified virus showed enhanced gene delivery to a number
of transformed cell lines that lacked CAR but expressed
v integrins. It will be of interest to determine whether
this approach will be useful for improving Ad in vivo gene therapy.
ROLE OF DYNAMIN, ACTIN, AND CELL SIGNALING IN ADENOVIRUS
ENTRY
|
|
|---|
Some of the earliest studies of Ad cell entry involved transmission electron microscopy. These early studies suggested that Ad is internalized into host cell by clathrin-mediated endocytosis (12, 70). Biochemical studies have subsequently supported this finding (39, 96). A genetic approach was used to determine whether the infectious pathway of Ad involves dynamin, a 100-kDa cytosolic GTPase which regulates clathrin-mediated endocytosis (24). HeLa cells expressing a dominant negative form of dynamin 1 (K44A) failed to support efficient Ad internalization or gene delivery (73, 99). These findings are consistent with the notion that the primary entry pathway of Ad is via the clathrin-coated pit pathway. It should be noted that expression of mutant dynamin does not completely abolish virus entry or infection. This suggests the possibility that Ad entry also occurs via a clathrin-independent endocytic pathway (55), perhaps mediated by the fiber interaction with CAR.
A major question arising from studies of Ad entry is whether
v integrins promote virus entry via specific cell
signaling events. A growing body of evidence indicates that
integrin-mediated signaling regulates cell adhesion, cell growth, and
cell migration (50, 69). Integrin clustering following
ligand binding is frequently associated with the reorganization of
actin and actin-associated proteins into focal adhesions which also
contain a number of signaling molecules such as protein and lipid
kinases that associate with the integrin
-subunit cytoplasmic domain
(16, 68). It has also been demonstrated that the actin
cytoskeleton and integrin signaling play a role in the cell entry of a
number of pathogenic bacteria (29). Earlier studies
indicated that disruption of cortical actin filaments by cytochalasins
blocked Ad entry and infection (70). More recently, the
actin cytoskeleton has been reported to play a role in
clathrin-mediated endocytosis of enveloped viruses (37) as
well as nonviral ligands (54).
A number of signaling molecules associate with integrins upon receptor
ligation by various components of the extracellular matrix including
the ERK1/ERK2 mitogen-activated protein (MAP) kinases (13,
80). These signaling molecules have been reported to be involved
in
v integrin-mediated cell motility (52).
Interestingly, the ERK1/ER2 MAP kinases appear to play little if any
role in
v integrin-mediated Ad endocytosis. Instead, Ad
internalization was shown to be regulated by a lipid kinase,
phosphatidylinositol-3-OH kinase (PI3K) (57). The
phospholipid products of PI3K are thought to act as second messengers
for a number of important biological processes including cell cycle
progression (33) and reorganization of the actin
cytoskeleton (101). Ad penton base interaction with
v integrins was specifically shown to activate the p85
subunit of PI3K, and activation was shown to be required for efficient virus internalization and infection (57). Pharmacologic
inhibitors or expression of dominant negative forms of PI3K but not
ERK1/ER2 MAP kinases also inhibited Ad internalization and infection.
Thus, cell motility and virus internalization mediated by the same
integrin appear to involve distinct signaling pathways (Fig.
3). In further support of this concept,
focal adhesion kinase, p125FAK, a signaling molecule known
to function upstream of the ERK1/ER2 MAP kinases, is phosphorylated and
activated upon adenovirus entry (57a) but this kinase is not
required for virus uptake into cells or infection. Activation of the
MAP kinase pathway, although not required for virus entry, may have
other consequences for the host including the production of
inflammatory cytokines (11).
|
An obvious question arising from these studies is that of how PI3K promotes virus uptake. PI3K is known to be linked to both the Ras and Rho signaling cascades (16, 44). These small GTPases, which cycle between an inactive GDP-bound form and an active GTP-bound form, have the capacity to alter the host cell actin cytoskeleton (65). Recently, we demonstrated that the Rho family GTPases, Rac1, CDC42, and RhoA, rather than Ras, promote Ad endocytosis (56). Further studies indicated that the mechanism by which Rho GTPases enhance virus uptake is via reorganization of the actin cytoskeleton. Thus, Ad uptake into cells was inhibited by treatment with cytochalasin D and also by the expression of effector domain mutants of Rac or CDC42 that impair cytoskeletal function but not JNK/MAP kinase pathway activation. Further studies are necessary to identify the downstream effectors of Rho GTPases that promote actin polymerization and virus uptake. The precise role of the actin cytoskeleton in viral endocytosis also remains to be determined. At least two possible roles for actin have been considered. Polymerized actin filaments may assist dynamin-mediated endosome formation (78) or perhaps increase the half-life of signaling complexes involved in endocytosis.
Studies of Ad cell entry have led to another important question: what
is the relevance of the Ad signaling pathway to the normal function of
the
v integrins? In this regard,
v
5 integrin has been reported to mediate
the internalization of a conformationally altered form of vitronectin,
the natural host ligand for this integrin receptor (67). A
region of the
5 integrin subunit cytoplasmic tail
containing the NPXY internalization motif has recently been implicated
in the association of the integrin with clathrin-coated portions of the
cell membrane (26). However, it is not yet clear whether the
molecular events required for the internalization of the monovalent
host ligand (vitronectin) by integrins are precisely the same as those
required for the internalization of the multivalent viral ligand
(penton base).
ROLE OF
V INTEGRINS IN
ADENOVIRUS-MEDIATED ENDOSOME DISRUPTION AND GENE DELIVERY
|
|
|---|
Integrin-mediated internalization of prebound Ad particles occurs relatively rapidly (5 min) at 37°C (39, 104). Once fully enclosed in cell endosomes, Ad particles disrupt the endosomal membrane and escape into the cytoplasm, where they begin their journey toward the cell nucleus. Since vesicle rupture occurs relatively rapidly, within 15 min at 37°C (39), it is likely that escape occurs from the early endosome prior to endosome fusion with lysosomal vacuoles. At present, there is relatively little information on the precise mechanisms involved in virus penetration of cell endosomes. Several studies, based on the used of lysosomatropic agents which affect vaculor pH, suggest that virus penetration requires exposure to mildly acidic pH conditions (39). However, other studies have questioned the validity of these findings (75). Further studies on this problem are needed to resolve this controversy.
The ability of Ad to efficiently escape lysosomal degradation has been exploited for gene delivery applications. Intact Ad particles (19, 22) or components of the virus capsid that mediate virus penetration have been conjugated to plasmid DNA to deliver genes to cells in vitro (31). Ad particles mediate the release of small molecules such as [3H]choline from cells at a pH optimum of 6.0 (83, 85, 102) and induce the formation of ion channels in model bilayer lipid membranes (9, 79).
Over the past several decades, there has been an accumulation of
evidence suggesting that the Ad penton base interaction with integrins
plays a central role in Ad escape from the cell endosome. Earlier
studies showed that the penton base played the major role in
Ad-mediated delivery of a endotoxin-growth factor conjugate to cells
(82), while more recent studies have reported that the
isolated penton base from Ad3 can be used to deliver DNA into cells
(31). At reduced pH, the penton base protein shows a high propensity to bind nonionic detergent (84). This raises the possibility that exposure to low pH induces a conformational change in
the penton base protein which allows a physical interaction (insertion)
with the endosomal membrane. Consistent with this view, previous
studies showed that the penton base protein is released from viral
particles at the stage of endosome release (39). In previous
studies, we demonstrated that integrin
v
5 rather than
v
3 interaction with the Ad2
penton base selectively mediates Ad membrane permeabilization and gene
delivery (102). The selective involvement of
v
5 integrin in membrane permeabilization appears to be due to the ability of this receptor to bind to the virus
protein at reduced pH compared to integrin
v
3. It should be noted that
v
5 interaction with the isolated Ad2
penton base alone does not induce membrane permeabilization
(102), and thus it is likely that other viral and/or host
cell factors participate in this process.
Recent work has indicated that the 23-kDa Ad cysteine protease also
participates in virus penetration (20). A
temperature-sensitive mutant Ad which contains a defective protease
fails to escape cell endosomes (38). Treatment of wild-type
Ad particles with protease inhibitors blocks infection as well as
Ad-mediated gene delivery (20). Interestingly, interaction
of the Ad with
v integrins was shown to be required for
protease activation and escape from the cell endosome (38).
Ad protein VI, a capsid protein located under the vertex region of the
virus particle (90), is also degraded following protease
activation, suggesting that protease activation may also be involved in
viral DNA uncoating as well as penetration. Clearly, further studies
are needed to define the precise molecular and cellular events
associated with Ad penetration.
STRUCTURE OF A FUNCTION-BLOCKING MONOCLONAL ANTIBODY
COMPLEXED WITH ADENOVIRUS
|
|
|---|
To gain further insights into the role of
v
integrin-mediated Ad entry, structural studies have been performed to
identify the sites of integrin interaction on virus particles. In the
earliest studies, the three-dimensional structure of Ad2 particles at
35 Å resolution was revealed by cryo-electron microscopy (cryo-EM) and
image reconstruction (88). Further refinements which
improved the resolution to 25 Å (90) allowed the
visualization of five protrusions, approximately 22 Å in diameter, on
each penton base protein. These protrusions were proposed to contain
the RGD sequence and additional flanking residues corresponding to the
site of integrin binding. To confirm this possibility, we examined the structure of Ad2 complexed with Fab fragments of function-blocking penton base monoclonal antibody (designated Dav-1) (89).
Peptide-mapping studies showed that the DAV-1 mAb recognized a linear
epitope of 9 amino acids containing the integrin-binding motif,
IRGDTFATR. This antibody also blocked penton base binding to
cells. Somewhat surprisingly, Fab fragments of DAV-1 but not intact
antibody molecules inhibited Ad infection, suggesting that Fab
fragments but not whole antibodies were able to fully occupy each of
the five RGD sites on the penton base protein. To investigate this
possibility further, we used an automated biosensor to measure the
kinetics and stoichiometry of antibody-Ad2 penton base interactions. We found that only two or three molecules of the intact DAV-1 monoclonal antibody could bind to the penton base protein whereas five Fab fragments could bind.
A cryo-EM structural study of the Ad2/DAV-1 Fab complex confirmed that the protrusions on the penton base contain the integrin-binding RGD sequence (89). It also revealed that the bound Fab fragments undergo a large range of motion since a large volume of weak, diffuse density was observed for the Fab (Fig. 4). Examination of the penton base in a reconstruction of Ad2 without bound antibody molecules showed a region of weak density at the top of the penton base protrusions, providing further evidence that the RGD peptide loop is quite mobile (Fig. 5). Cryo-EM studies performed with the isolated penton base of Ad3 also suggested that the RGD protrusions are flexible (81). Interestingly, the position of the protrusions was observed to shift slightly in the presence or absence of the central fiber protein. This latter observation was also shown for Ad2 when comparing the structures of wild-type and fiberless particles (97). This structural change does not significantly affect integrin-binding function, since Ad particles lacking the fiber protein appear to retain the ability to infect monocytic cells via an integrin-dependent pathway (97).
|
|
STRUCTURE OF INTEGRIN
V
5 BOUND TO
ADENOVIRUS
|
|
|---|
In recent cryo-EM structural studies, we examined the
complex of Ad with soluble
v
5 integrin
molecules (59). Given the high degree of mobility of the RGD
surface loop in Ad2, we also examined the structure of another
serotype, Ad12, which has a much smaller RGD loop and therefore is more
likely to provide detailed structural information (Fig.
6). The cryo-EM structures of Ad2 and
Ad12 revealed a ring of integrin density above the penton base RGD
loops of each virus serotype (14a). However, the integrin
density in the Ad2 complex was found to be weak and diffuse whereas
that of the Ad12 complex was compact and well defined, thus allowing a
better visualization of the integrin structure. Cryo-EM visualization
of Ad12 revealed five closely packed integrin molecules per penton
base, a finding supported by kinetic analyses. In contrast, kinetic
analyses indicated that only 1.7 DAV-1 monoclonal antibodies are
capable of binding. Thus, the structure of Ad facilitates the
interaction with cell integrins while restricting the binding of
potentially neutralizing antibodies. Each integrin molecule was shown
to consist of two discrete subdomains, a globular domain with an
RGD-binding cleft of approximately 20 Å in diameter and a distal
domain made up of extended, flexible tails (Fig.
7).
|
|
These recent structural findings also suggest that the precise spatial arrangement of five RGD protrusions on the penton base promotes integrin-clustering and cell-signaling events required for virus internalization. Three lines of evidence support this concept. The first is that the Ad penton base protein, but not a monomeric RGD peptide (50-mer) derived from the penton base sequence, activates the p72syk kinase and promotes B-lymphoblastoid cell adhesion (91). The second is that the spacing of the integrin-binding sites on Ad is virtually identical to that of an unrelated virus, foot-and-mouth disease virus (FMDV) (1, 51) which also uses integrins for infection. Finally, the cryo-EM structure of the Ad12-integrin complex revealed substantial regions of contact between the integrin extracellular domains.
OTHER VIRAL PATHOGENS THAT USE INTEGRINS FOR INFECTION
|
|
|---|
At least two members of the Picornaviridae
family of nonenveloped viruses use integrins for infection. These
include FMDV (51) and coxsackievirus A9 (49, 77).
For both of these viruses, the role of the integrin in infection
appears to be at the level of virus attachment. Integrin
2
1 is a receptor for echovirus 1 (6), and this promotes viral attachment. Two coat proteins of rotavirus, a virus which is a major cause of acute gastrointestinal disease of humans, are also reported to interact with integrins
2
1,
x
2, and
4
1, and this interaction may be required
to complete the infectious process (21).
More recently, several other human viruses have been identified as
using integrins for infection. The newly emerged hantaviruses, which
are associated with severe pulmonary syndrome disease in humans, use
3-type integrins for cell entry (34);
however, the stage at which the integrin acts has not yet been
reported. AAV-2 has recently been reported to use
v
5 integrin as a coreceptor for entry
(92). Initial attachment of AAV-2 to cells is mediated by
interaction with heparin sulfate proteoglycan (93) and/or fibroblast growth factor receptor 1 (74). Secondary
interaction with integrin
v
5 facilitates
AAV-2 entry. Interestingly, the AVV-2 interaction with
v
5 integrin appears to be RGD
independent, since synthetic RGD peptides do not interfere with
AAV-2-integrin interaction and the AAV-2 coat protein lacks an RGD
sequence. It will be of interest to identify the non-RGD sequences
involved in viral interaction with this integrin.
CONCLUSIONS AND FUTURE DIRECTIONS
|
|
|---|
It is a remarkable feat that an organism as small as Ad has
provided such a wealth of knowledge of several important host cell
processes. In this review, we have discussed the earliest interactions
of Ad with its cellular receptors and focused on the role of the virus
internalization receptors, integrins
v
3 and
v
5. While evidence has accumulated
that integrins promote Ad entry both in vitro and in vivo, the precise
mechanism by which virus uptake is accomplished is not completely
understood. It is clear that Ad entry requires a signaling pathway
involving PI3K, the Rho family of small GTPases, and polymerization of
actin filaments. However, the specific role for these molecules in Ad entry remains to be determined. Even less well understood is how integrin
v
5 facilitates the escape of
viral particles from the cell endosome. Integrins are required but not
sufficient for virus penetration, and therefore other viral or cellular
molecules must be involved in the process. Other than the 23-kDa Ad
cysteine protease, the identities of these molecules remain to be determined.
From a structural point of view, recent cryo-EM reconstructions of Ad particles in a complex with function-blocking antibodies or soluble integrins have provided some clues to how the architecture of Ad promotes receptor clustering while restricting antibody binding.
The current state of knowledge of Ad structure and biology has already led to significant improvements in first-generation viral vectors for gene therapy. Specifically, modifications of the virus fiber protein or the penton base have allowed an expansion of vector tropism in vitro. We anticipate that with an even greater understanding of the structural features of virus-receptor interactions as well as the precise cellular events involved in Ad entry and uncoating, it should be possible to increase the specificity of vector targeting in vivo. This may allow a reduction in the amount of vector needed to achieve a therapeutic response, thereby lessening the severity of the host immune response. Further progress in the area of cellular and molecular biology as well as virology and structural biology will have to come together to result in success in this endeavor.
ACKNOWLEDGMENTS
|
|
|---|
We thank present and former members of the Nemerow, Stewart, and Cheresh laboratories for their contributions during the course of these studies, and we thank Catalina Hope and Joan Gausepohl for assistance with the manuscript.
This work was supported in part by NIH grants EY11431, HL54352, AI42929 and RR00833.
FOOTNOTES
* Corresponding author. Mailing address: Department of Immunology, The Scripps Research Institute, 10550 North Torrey Pines Rd., La Jolla, CA 92037. Phone: (619) 784-8072. Fax: (619) 784-8472. E-mail: gnemerow{at}scripps.edu.
Paper 12291-IMM from The Scripps Research Institute.
REFERENCES
|
|
|---|
| 1. | Acharya, R., E. Fry, D. Stuart, G. Fox, D. Rowlands, and F. Brown. 1989. The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 337:709-716[Medline]. |
| 2. | Akke, M., J. Liu, J. Cavanagh, H. P. Erickson, and A. G. Palmer, III. 1998. Pervasive conformational fluctuations on microsecond time scales in a fibronectin type III domain. Nat. Struct. Biol. 5:55-59[Medline]. |
| 3. |
Bai, M.,
L. Campisi, and P. Freimuth.
1994.
Vitronectin receptor antibodies inhibit infection of HeLa and A549 cells by adenovirus type 12 but not by adenovirus type 2.
J. Virol.
68:5925-5932 |
| 4. |
Bai, M.,
B. Harfe, and P. Freimuth.
1993.
Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells.
J. Virol.
67:5198-5205 |
| 5. |
Bergelson, J. M.,
J. A. Cunningham,
G. Droguett,
E. A. Kurt-Jones,
A. Krithivas,
J. S. Hong,
M. S. Horwitz,
R. L. Crowell, and R. W. Finberg.
1997.
Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5.
Science
275:1320-1323 |
| 6. |
Bergelson, J. M.,
M. P. Shepley,
B. M. C. Chan,
M. E. Hemler, and R. W. Finberg.
1992.
Identification of the integrin VLA-2 as a receptor for echovirus I.
Science
255:1718-1720 |
| 7. |
Berget, S. M.,
C. Moore, and P. A. Sharp.
1977.
Spliced segments at the 5' terminus of adenovirus 2 late mRNA.
Proc. Natl. Acad. Sci. USA
74:3171-3175 |
| 8. |
Bischoff, J. R.,
D. H. Kirn,
A. Williams,
C. Heise,
S. Horn,
M. Muna,
L. Ng,
J. A. Nye,
A. Sampson-Johannes,
A. Fattaey, and F. McCormick.
1996.
An adenovirus mutant that replicates selectively in p53 deficient human tumor cells.
Science
274:373-376 |
| 9. | Blumenthal, R., P. Seth, M. C. Willingham, and I. Pastan. 1986. pH-dependent lysis of liposomes by adenovirus. Biochemistry 25:2231-2237[Medline]. |
| 10. | Brody, S. L., and R. G. Crystal. 1994. Adenovirus-mediated in vivo gene therapy. Ann. N. Y. Acad. Sci. 716:90-103[Abstract]. |
| 11. | Bruder, J. T., and I. Kovesdi. 1997. Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J. Virol. 71:398-404[Abstract]. |
| 12. | Chardonnet, Y., and S. Dales. 1970. Early events in the interaction of adenoviruses with HeLa cells. I. Penetration of type 5 and intracellular release of the DNA genome. Virology 40:462-477[Medline]. |
| 13. | Chen, Q., M. S. Kinch, T. H. Lin, K. Burridge, and R. L. Juliano. 1994. Integrin-mediated cell adhesion activates mitogen-activated protein kinases. J. Biol. Chem. 6:26602-26605. |
| 14. | Chinnadurai, G. 1983. Adenovirus 2lp+locus codes for a 19 kd tumor antigen that plays an essential role in cell transformation. Cell 33:759-766[Medline]. |
| 14a. |
Chiu, C. Y.,
P. Mathias,
G. R. Nemerow, and P. L. Stewart.
1999.
Structure of adenovirus complexed with its internalization receptor, v 5 integrin.
J. Virol.
73:6759-6768 |
| 15. | Chow, L. T., R. E. Gelinas, T. R. Broker, and R. J. Roberts. 1977. An amazing sequence arrangement at the 5' ends of adenovirus 2 messenger RNA. Cell 12:1-8[Medline]. |
| 16. |
Clark, E. A., and J. S. Brugge.
1995.
Integrins and signal transduction pathways: The road taken.
Science
268:233-239 |
| 17. | Cooper, N. R. 1999. Biology of the complement system In In J. Gallin and R. Snyderman (ed.), p. 281-315. Inflammation: basic principles and clinical correlates, 3rd ed. Lippincott-Raven, Philadelphia, Pa.. |
| 18. | Copie, V., Y. Tomita, S. K. Akiyama, S. Aota, K. M. Yamada, R. M. Venable, and R. W. Pastor. 1998. Solution structure and dynamics of linked cell attachment modules of mouse. J. Mol. Biol. 277:663-682[Medline]. |
| 19. |
Cotten, M.,
E. Wagner,
K. Zatloukal, and M. L. Birnstiel.
1993.
Chicken adenovirus (CELO virus) particles augment receptor-mediated DNA delivery to mammalian cells and yield exceptional levels of stable transformants.
J. Virol.
67:3777-3785 |
| 20. | Cotten, M., and J. M. Weber. 1995. The adenovirus protease is required for virus entry into host cells. Virology 213:494-502[Medline]. |
| 21. |
Coulson, B. S.,
S. L. Londrigan, and D. J. Lee.
1997.
Rotavirus contains integrin ligand sequences and a disintegrin-like domain that are implicated in virus entry into cells.
Proc. Natl. Acad. Sci. USA
94:5389-5394 |
| 22. | Curiel, D. T. 1994. High-efficiency gene transfer employing adenovirus-polylysine-DNA complexes. Nat. Immun. 13:141-164[Medline]. |
| 23. |
Dai, Y.,
E. M. Schwarz,
D. Gu,
W. Zhang,
N. Sarvetnick, and I. M. Verma.
1995.
Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.
Proc. Natl. Acad. Sci. USA
92:1401-1405 |
| 24. |
Damke, H.,
T. Baba,
D. E. Warnock, and S. L. Schmid.
1994.
Induction of mutant dynamin specifically blocks endocytic coated vesicle formation.
J. Cell Biol.
127:915-934 |
| 25. | Davison, A. J., E. A. R. Telford, M. S. Watson, K. McBride, and V. Mautner. 1993. The DNA sequence of adenovirus Type 40. J. Mol. Biol. 234:1308-1316[Medline]. |
| 26. | DeDeyne, P. G., A. O'Neill, W. G. Resneck, G. M. Dmytrenko, D. W. Pumplin, and R. J. Bloch. 1998. The vitronectin receptor associates with clathrin-coated membrane domains via the cytoplasmic domain of its beta5 subunit. J. Cell Sci. 111:2729-2740[Abstract]. |
| 27. |
De Nichilo, M. O., and G. F. Burns.
1993.
Granulocyte-macrophage and macrophage colony-stimulating factors differentially regulate v integrin expression on cultured human macrophages.
Proc. Natl. Acad. Sci. USA
90:2517-2521 |
| 28. |
Dmitriev, I.,
V. Krasnykh,
C. R. Miller,
M. Wang,
E. Kashentseva,
G. Mikheeva,
N. Belousova, and D. T. Curiel.
1998.
An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism.
J. Virol.
72:9706-9713 |
| 29. | Dramsi, S., and P. Cossart. 1998. Intracellular pathogens and the actin cytoskeleton. Annu. Rev. Cell Dev. Biol. 14:137-166[Medline]. |
| 30. | Everett, S. F., and H. S. Ginsberg. 1958. A toxin-like material separable from type 5 adenovirus particles. Virology 6:770-771[Medline]. |
| 31. | Fender, P., R. W. H. Ruigrok, E. Gout, S. Buffet, and J. Chroboczek. 1997. Adenovirus dodecahedron, a new vector for human gene transfer. Nat. Biotechnol. 15:52-56[Medline]. |
| 32. | Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877[Abstract]. |
| 33. | Franke, T. F., D. R. Kaplan, and L. C. Cantley. 1997. PI3K: downstream AKTion blocks apoptosis. Cell 88:435-437[Medline]. |
| 34. |
Gavrilovskaya, I. N.,
M. Shepley,
R. Shaw,
M. H. Ginsberg, and E. R. Mackow.
1998.
3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure.
Proc. Natl. Acad. Sci. USA
95:7074-7079 |
| 35. |
Geraghty, R. J.,
C. Krummenacher,
G. H. Cohen,
R. J. Eisenberg, and P. G. Spear.
1998.
Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor.
Science
280:1618-1620 |
| 36. |
Goldman, M. J., and J. M. Wilson.
1995.
Expression of v 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway.
J. Virol.
69:5951-5958[Abstract].
|
| 37. |
Gottlieb, T. A.,
I. E. Ivanov,
M. Adesnik, and D. D. Sabatini.
1993.
Actin microfilaments play a critical role in endocytosis at the apical but not the basolateral surface of polarized epithelial cells.
J. Cell Biol.
120:695-709 |
| 38. | Greber, U. F., P. Webster, A. Helenius, and J. Weber. 1996. The role of the adenovirus protease in virus entry into cells. EMBO J. 15:1766-1777[Medline]. |
| 39. | Greber, U. F., M. Willetts, P. Webster, and A. Helenius. 1993. Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75:477-486[Medline]. |
| 40. | Grotewiel, M. S., C. D. O. Beck, K.-H. Wu, X.-R. Zhu, and R. L. Davis. 1998. Integrin-mediated short-term memory in Drosophila. Nature 391:455-460[Medline]. |
| 41. |
Hierholzer, J. C.
1992.
Adenoviruses in the immunocompromised host.
Clin. Microbiol. Rev.
5:262-274 |
| 42. | Hong, S. S., and P. Boulanger. 1995. Protein ligands of the human adenovirus type 2 outer capsid identified by biopanning of a phage-displayed peptide library on separate domains of wild-type and mutant penton capsomers. EMBO J. 14:4714-4727[Medline]. |
| 43. | Horwitz, M. S. 1996. Adenovirus, p. 2149-2171. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa. |
| 44. |
Hotchin, N., and A. Hall.
1995.
The assembly of integrin adhesion complexes requires both extracellular matrix and intracellular rho/rac GTPases.
J. Cell Biol.
131:1857-1865 |
| 45. |
Huang, S.,
R. I. Endo, and G. R. Nemerow.
1995.
Upregulation of integrins v 3 and v 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery.
J. Virol.
69:2257-2263[Abstract].
|
| 46. | Huang, S., T. Kamata, Y. Takada, Z. M. Ruggeri, and G. R. Nemerow. 1996. Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J. Virol. 70:4502-4508[Abstract]. |
| 47. | Huang, S., V. Reddy, N. Dasgupta, and G. R. Nemerow. 1999. A single amino acid in the adenovirus type 37 fiber confers binding to human conjunctival cells. J. Virol. 73:1600-1698. |
| 48. |
Huang, S.,
D. G. Stupack,
P. Mathias,
Y. Wang, and G. Nemerow.
1997.
Growth arrest of Epstein-Barr virus immortalized B lymphocytes by adenovirus-delivered ribozymes.
Proc. Natl. Acad. Sci. USA
94:8156-8161 |
| 49. | Hughes, P. J., C. Horsnell, T. Hyypia, and G. Stanway. 1995. The coxsackievirus A9 RGD motif is not essential for virus viability. J. Virol. 69:8035-8040[Abstract]. |
| 50. | Hynes, R. O. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11-25[Medline]. |
| 51. |
Jackson, T.,
A. Sharma,
R. A. Ghazaleh,
W. E. Blakemore,
F. M. Ellard,
D. L. Simmons,
J. W. Newman,
D. I. Stuart, and A. M. King.
1997.
Arginine-glycine-aspartic acid-specific binding by foot-and mouth disease viruses to the purified integrin v 3 in vitro.
J. Virol.
71:8357-8361[Abstract].
|
| 52. |
Klemke, R. L.,
S. Cai,
A. L. Giannini,
P. J. Gallagher,
P. de Lanerolle, and D. A. Cheresh.
1997.
Regulation of cell motility by mitogen-activated protein kinase.
J. Cell Biol.
137:481-492 |
| 53. |
Knowles, M. R.,
K. W. Hohneker,
Z. Zhou,
J. C. Olsen,
T. L. Noah,
P. C. Hu,
M. W. Leigh,
J. F. Engelhardt,
L. J. Edwards,
K. R. Jones, et al.
1995.
A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.
N. Engl. J. Med.
333:823-831 |
| 54. |
Lamaze, C.,
L. M. Fujimoto,
H. L. Yin, and S. L. Schmid.
1997.
The actin cytoskeleton is required for receptor-mediated endocytosis in mammalian cells.
J. Biol. Chem.
272:20332-20335 |
| 55. | Lamaze, C., and S. L. Schmid. 1995. The emergence of clathrin-independent pinocytic pathways. Curr. Biol. 7:573-580. |
| 56. |
Li, E.,
D. Stupack,
G. Bokoch, and G. R. Nemerow.
1998.
Adenovirus endocytosis requires reorganization of the actin cytoskeleton mediated by Rho family GTPases.
J. Virol.
72:8806-8812 |
| 57. |
Li, E.,
D. Stupack,
D. Cheresh,
R. Klemke, and G. Nemerow.
1998.
Adenovirus endocytosis via v integrins requires phosphoinositide-3-OH-kinase.
J. Virol.
72:2055-2061 |
| 57a. | Li, E., et al. Submitted for publication. |
| 58. | Londergan, T. A., and M. P. Walzak. 1994. Hemorrhagic cystitis due to adenovirus infection following bone marrow transplantation. J. Urol. 151:1013-1014[Medline]. |
| 59. |
Mathias, P.,
M. Galleno, and G. R. Nemerow.
1998.
Interactions of soluble recombinant integrin v 5 with human adenoviruses.
J. Virol.
72:8669-8675 |
| 60. |
Mathias, P.,
T. J. Wickham,
M. Moore, and G. Nemerow.
1994.
Multiple adenovirus serotypes use v integrins for infection.
J. Virol.
68:6811-6814 |
| 61. | McGrath, D., M. E. Falagas, R. Freeman, R. Rohrer, R. Fairchild, C. Colbach, and D. R. Snydman. 1998. Adenovirus infection in adult orthotopic liver transplant recipients: Incidence and clinical significance. J. Infect. Dis. 177:459-462[Medline]. |
| 62. | Michaels, M. G., M. Green, E. R. Wald, and T. E. Starzl. 1992. Adenovirus infection in pediatric liver transplant recipients. J. Infect. Dis. 165:170-174[Medline]. |
| 63. |
Miller, C. R.,
D. J. Buchsbaum,
P. N. Reynolds,
J. T. Douglas,
G. Y. Gillespie,
M. S. Mayo,
D. Raben, and D. T. Curiel.
1998.
Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer.
Cancer Res.
58:5738-5748 |
| 64. | Neumann, R., J. Chroboczek, and B. Jacrot. 1988. Determination of the nucleotide sequence for the penton-base gene of human adenovirus type 5. Gene 69:153-157[Medline]. |
| 65. | Nobes, C. D., and A. Hall. 1995. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81:53-62[Medline]. |
| 66. | Oldstone, M. B. A. 1998. Introduction to the principles of virology, p. 8-15. In M. B. A. Oldstone (ed.), Viruses, plagues, & history Oxford University Press, New York, N.Y. |
| 67. |
Panetti, T. S., and P. J. McKeown-Longo.
1993.
The v 5 integrin receptor regulates receptor-mediated endocytosis of vitronectin.
J. Biol. Chem.
268:11492-11495 |
| 68. | Parsons, J. T. 1996. Integrin-mediated signaling: regulation by protein tyrosine kinases and small GTP-binding proteins. Curr. Opin. Cell Biol. :146:152. |
| 69. | Parsons, J. T., M. D. Schaller, J. Hildebrand, T.-H. Leu, A. Richardson, and C. Otey. 1994. Focal adhesion kinase: structure and signaling. J. Cell Sci. Suppl. 18:109-113[Medline]. |
| 70. | Patterson, S., and W. C. Russell. 1983. Ultrastructural and immunofluorescence studies of early events in adenovirus-HeLa cell interactions. J. Gen. Virol. 64:1091-1099[Abstract]. |
| 71. | Pereira, H. G. 1958. A protein factor responsible for the early cytopathic effect of adenoviruses. Virology 6:601-611[Medline]. |
| 72. | Philipson, L., P. L. Stewart, and R. M. Burnett. 1995. The molecular repertoire of adenovirus I. Springer-Verlagug, Berlin, Germany. |
| 73. |
Pickles, R. J.,
D. McCarty,
H. Matsui,
P. J. Hart,
S. H. Randell, and R. C. Boucher.
1998.
Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer.
J. Virol.
72:6014-6023 |
| 74. | Qing, K., C. Mah, J. Hansen, S. Zhou, V. Dwarki, and A. Srivastava. 1999. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med. 5:71-77[Medline]. |
| 75. | Rodriguez, E., and E. Everitt. 1996. Adenovirus uncoating and nuclear establishment are not affected by weak-base amines. J. Virol. 70:3470-3477[Abstract]. |
| 76. |
Roelvink, P. W.,
A. Lizonova,
J. G. M. Lee,
Y. Li,
J. M. Bergelson,
R. W. Finberg,
D. E. Brough,
I. Kovesdi, and T. J. Wickham.
1998.
The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F.
J. Virol.
72:7909-7915 |
| 77. |
Roivaninen, M.,
T. Hypiä,
L. Pirainen,
N. Kalkkinen,
G. Stanway, and T. Hovi.
1991.
RGD-dependent entry of coxsackievirus A9 into host cells and its bypass after cleavage of VP1 protein by intestinal proteases.
J. Virol.
65:4735-4740 |
| 78. | Roos, J., and R. B. Kelly. 1997. Is dynamin really a `pinchase'. Trends Cell Biol. 7:257-259. |
| 79. | Rosenkranz, A. A., Y. N. Antonenko, O. A. Smirnova, G. K. Yurov, B. S. Naroditsky, and A. S. Sobolev. 1997. Avian adenovirus induces ion channels in model bilayer lipid membranes. Biochem. Biophys. Res. Commun. 236:750-753[Medline]. |
| 80. | Schlaepfer, D. D., S. K. Hanks, T. Hunter, and P. vanderGeer. 1994. Integrin-Mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372:786-791[Medline]. |
| 81. | Schoehn, G., P. Fender, J. Chroboczek, and E. A. Hewat. 1996. Adenovirus 3 penton dodecahedron exhibits structural changes of the base on fibre binding. EMBO J. 15:6841-6846[Medline]. |
| 82. |
Seth, P.,
D. Fitzgerald,
H. Ginsberg,
M. Willingham, and I. Pastan.
1984.
Evidence that the penton base of adenovirus is involved in potentiation of toxicity of Pseudomonas exotoxin conjugated to epidermal growth factor.
Mol. Cell. Biol.
4:1528-1533 |
| 83. |
Seth, P.,
I. Pastan, and M. C. Willingham.
1985.
Adenovirus-dependent increase in cell membrane permeability.
J. Biol. Chem.
260:9598-9602 |
| 84. |
Seth, P.,
M. C. Wilingham, and I. Pastan.
1985.
Binding of adenovirus and its external proteins to Triton X-114.
J. Biol. Chem.
260:14431-14434 |
| 85. |
Seth, P.,
M. C. Willingham, and I. Pastan.
1984.
Adenovirus-dependent release of 51Cr from KB cells at an acidic pH.
J. Biol. Chem.
259:14350-14353 |
| 86. | Shields, A. F., R. C. Hackman, K. H. Fife, L. Corey, and J. D. Meyers. 1985. Adenovirus infections in patients undergoing bone-marrow transplantation. N. Engl. J. Med. 312:529-533[Abstract]. |
| 87. |
Sprengel, J.,
B. Schmitz,
D. Heuss-Neitzel,
C. Zock, and W. Doerfler.
1994.
Nucleotide sequence of human adenovirus type 12 DNA: comparative functional analysis.
J. Virol.
68:379-389 |
| 88. | Stewart, P. L., R. M. Burnett, M. Cyrklaff, and S. D. Fuller. 1991. Image reconstruction reveals the complex molecular organization of adenovirus. Cell 67:145-154[Medline]. |
| 89. | Stewart, P. L., C. Y. Chiu, S. Huang, T. Muir, Y. Zhao, B. Chait, P. Mathias, and G. R. Nemerow. 1997. Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization. EMBO J. 16:1189-1198[Medline]. |
| 90. | Stewart, P. L., S. D. Fuller, and R. M. Burnett. 1993. Difference imaging of adenovirus: bridging the resolution gap between X-ray crystallography and electron microscopy. EMBO J. 12:2589-2599[Medline]. |
| 91. |
Stupack, D. G.,
E. Li,
J. A. Kehler,
R. L. Geahlen,
K. Hahn,
G. R. Nemerow, and D. A. Cheresh.
1999.
Matrix valency regulates integrin-mediated lymphoid adhesion via Syk-kinase.
J. Cell Biol.
144:777-787 |